期刊文献+

一种新型检测肿瘤组织特征的等效电容测量系统的优化设计和可行性分析 被引量:1

An Optimized Design of New Features to Detect Tumor Tissue Equivalent Apacitance Measurement System and Feasibility Analysis
下载PDF
导出
摘要 不同阶段的癌细胞和正常细胞有明显的容抗特性差异,为寻找一种廉价、非介入式的、可连续实时检测的癌组织早期诊断方法,设计了并验证一套高分辨率的容抗测量系统。采用DDS 扫频技术、电压电流转换电路、匹配电感以及模拟乳腺容抗负载构成交变电流激励的LC谐振系统,测量谐振频率计算生物组织等效电容值,不同的电容值会反映病理阶段信息。在100~1000 pF的模拟电容负载测量中,测得该系统的电容分辨率达到8 pF。该系统可初步用于人体组织等效容抗测量,为癌组织的早期风险预警提供一种新的方法。 Different stages of cancer cells and normal cells have significant difference in capacitance.Looking for an inexpensive, non-invasive method for early diagnosis of cancer,a high-resolution bio-tissue capacitance measurement system was designed.The system consisted of DDS module,voltage-current conversion circuit,matching inductor and simulation capacitive and peak detection circuit.When the system was driven by alternating current,the circuit would resonate.The breast equivalent capacitance could be cal-culated by matching inductor and resonant frequency.Different equivalent capacitor values would reflect the pathological stage.When the simulation capacitance was 100~1000 pF,the system capacitance resolution was 8 pF.The system can be used for bio-tissue e-quivalent capacitance measurements,providing a new diagnosis of cancer early warning.
出处 《生物医学工程研究》 2014年第2期76-81,共6页 Journal Of Biomedical Engineering Research
基金 国家自然科学基金资助项目(61271063) 浙江省教育厅科研计划资助项目(Y201223324) 浙江省科技计划公益项目(2013C33164)
关键词 癌组织检测 等效电容 谐振 电容测量 分辨率 Cancer warning Equivalent capacitance Resonance Capacitance measurement Resolution
  • 相关文献

参考文献22

  • 1代敏,李霓,李倩,杨琳,陈玉恒.全球肿瘤预防控制概况[J].中国肿瘤,2011,20(1):21-25. 被引量:36
  • 2Jemal A, Siegel R, Ward E,et al. Cancer Statistics [ J ] . CA Cancer J. Clin,2009,59(4) :225 -249.
  • 3程柳柳,李俊.乳腺癌早期诊断技术[J].国际肿瘤学杂志,2013,40(6):453-455. 被引量:3
  • 4陈冬云.基于混频扫描方式的乳腺癌阻抗成像研究[D].东南大学,2007.
  • 5甄诚.阻抗乳腺扫描(EIS)系统改进的部分关键技术研究[D].第四军医大学,2007.
  • 6Alexander F A, Price J D T, Bhansali S. From Cellular cultures to cel lular spheroids:is impedance spectroscopy a viable tool for monitoring muhicellular spheroid (MCS) drug models? [J]. IEEE Reviews In Biomedical Engineering,2013,6:63 - 76.
  • 7Tao Dai and Andy Adler. In Vivo blood characterization from bioim- pedance spectroscopy of blood Pooling [J]. IEEE Transactions On In- strumentation And Measurement, 2009,58( 11 ) :3831 - 3838.
  • 8Weyer S, Othlingsh"ofer L R, Walter M, et al. Evaluation of bioimped- ance spectroscopy for the monitoring of the fluid status In an animal Model,2012 Ninth International Conference on Wearable and Im- plantable Body Sensor Networks[ C ]. 2012.22 - 26.
  • 9Guo feng Qiao, Wei Wang, Wei Duan, et al. Bioimpedance analysis for the characterization of breast cancer ceils in suspension[J]. IEEE Transactions On Biomedical Engineering, 2012,59 ( 8 ) : 2312 - 2319.
  • 10李滚,李斌,严雅静,杨思凡,庞小峰.人体组织等效电学参数的计算与应用[J].材料导报,2011,25(16):153-155. 被引量:4

二级参考文献40

  • 1左红艳,王德文,彭瑞云,王水明,高亚兵,胡文华,董波,张志毅,张飒.电磁辐射对原代培养海马神经元的损伤效应及其机制探讨[J].生物物理学报,2007,23(1):47-53. 被引量:12
  • 2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010 Jun 17. [Epub ahead of print].
  • 3Danaei G, Vander Hoorn S, Lopez AD, et al. Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behaviotiral and environmental risk factors [J]. Lancet, 2005, 366(9499):1784-1793.
  • 4International Union against Cancer. Global action against cancer[M]. Geneva: WHO, 2005.
  • 5World Health Organization. 58th World Health Assembly approved resolution on cancer prevention and control [EB/OL]. http://www.who.int/cancer/ eb1143/cn/, 2005-05-01.
  • 6World Health Organization. WHO's fight against cancer: strategies that prevent, cure and care [M]. Geneva: WHO, 2007.
  • 7World Health Organization. Cancer control: knowledge into action [M]. Geneva: WHO, 2005.
  • 8World Health Organization. National cancer control programmes: policies and managerial guidelines [M]. 2nd ed. Geneva: WHO, 2002.
  • 9Anindo MI, Yaqinuddin A. Insights into the potential use of micro-RNAs as biomarker in cancer. Int 1 Surg, 2012, 10(9) : 443-449.
  • 10Peter ME. Let-7 and miR-2oo microRNAs: guardians against pluripo-tency and cancer progression. Cell Cycle, 2009, 8(6): 843-852.

共引文献40

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部